These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 15918002)

  • 1. An indium:calcium phosphate colloid that specifically targets fibrin.
    Makowski GS; Ramsby ML; Ramsby GR
    J Biomed Sci; 2005; 12(2):421-9. PubMed ID: 15918002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effect of calcium phosphate and calcium pyrophosphate on binding of matrix metalloproteinases to fibrin: comparison to a fibrin-binding protease from inflammatory joint fluids.
    Makowski GS; Ramsby ML
    Clin Exp Immunol; 2004 Apr; 136(1):176-87. PubMed ID: 15030529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transferrin-mediated uptake of radionuclides by the testis.
    Hoyes KP; Morris ID; Hendry JH; Sharma HL
    J Nucl Med; 1996 Feb; 37(2):336-40. PubMed ID: 8667073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysfibrinogen Kagoshima with the amino acid substitution gammaThr-314 to Ile: analyses of molecular abnormalities and thrombophilic nature of this abnormal molecule.
    Niwa K; Mimuro J; Miyata M; Sugo T; Ohmori T; Madoiwa S; Tei C; Sakata Y
    Thromb Res; 2008; 121(6):773-80. PubMed ID: 17854865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colloids decrease clot propagation and strength: role of factor XIII-fibrin polymer and thrombin-fibrinogen interactions.
    Nielsen VG
    Acta Anaesthesiol Scand; 2005 Sep; 49(8):1163-71. PubMed ID: 16095459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of cytolytic neutrophil activation in vitro by amorphous hydrated calcium phosphate as a model of biomaterial inflammation.
    Edwards FC; Taheri A; Dann SC; Dye JF
    J Biomed Mater Res A; 2011 Mar; 96(3):552-65. PubMed ID: 21254387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Release of fibrinopeptides by the slow and fast forms of thrombin.
    Vindigni A; Di Cera E
    Biochemistry; 1996 Apr; 35(14):4417-26. PubMed ID: 8605191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fabrication and physical and biological properties of fibrin gel derived from human plasma.
    Zhao H; Ma L; Zhou J; Mao Z; Gao C; Shen J
    Biomed Mater; 2008 Mar; 3(1):015001. PubMed ID: 18458488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protransglutaminase (factor XIII) mediated crosslinking of fibrinogen and fibrin.
    Siebenlist KR; Meh DA; Mosesson MW
    Thromb Haemost; 2001 Nov; 86(5):1221-8. PubMed ID: 11816711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of the binding of 114mIn radiotracer to human serum components by ultrafiltration and chromatography.
    Van Hulle M; De Cremer K; Cornelis R
    Fresenius J Anal Chem; 2000; 368(2-3):293-6. PubMed ID: 11220595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-linked alpha s gamma t-chain hybrids in plasma clots studied by 1D- and 2D electrophoresis and western blotting.
    Grøn B; Filion-Myklebust C; Bjørnsen S; Haidaris P; Brosstad F
    Thromb Haemost; 1993 Sep; 70(3):438-42. PubMed ID: 8259545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel fibrin gel derived from hyaluronic acid-grafted fibrinogen.
    Yang CL; Chen HW; Wang TC; Wang YJ
    Biomed Mater; 2011 Apr; 6(2):025009. PubMed ID: 21393811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of carboxypeptidase N to fibrinogen and fibrin.
    Talens S; Lebbink JH; Malfliet JJ; Demmers JA; Uitte de Willige S; Leebeek FW; Rijken DC
    Biochem Biophys Res Commun; 2012 Oct; 427(2):421-5. PubMed ID: 23000409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clottability and cross-linking reactivity of fibrin(ogen) following differential release of fibrinopeptides A and B.
    Furlan M; Seelich T; Beck EA
    Thromb Haemost; 1976 Dec; 36(3):582-92. PubMed ID: 14415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluorogenic fibrinogen and fibrin facilitate macromolecular assembly and dynamic assay of picomolar levels of plasminogen activators under well mixed conditions.
    Wu JH; Diamond SL
    Thromb Haemost; 1995 Aug; 74(2):711-7. PubMed ID: 8585011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrinogen and fibrin polymerization: appraisal of the binding events that accompany fibrin generation and fibrin clot assembly.
    Mosesson MW
    Blood Coagul Fibrinolysis; 1997 Jul; 8(5):257-67. PubMed ID: 9282789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The monoclonal antibody that recognizes an epitope in the C-terminal region of the fibrinogen alpha-chain reacts with soluble fibrin and fibrin monomer generated by thrombin but not with those formed as plasmin degradation products.
    Suzuki A; Ebinuma H; Matsuo M; Miyazaki O; Yago H
    Thromb Res; 2007; 121(3):377-85. PubMed ID: 17561232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo distribution and speciation of [114mIn]InCl3 in the Wistar rat.
    Van Hulle M; De Cremer K; Cornelis R; Lameire N
    J Environ Monit; 2001 Feb; 3(1):86-90. PubMed ID: 11253025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Citrullinated fibrinogen inhibits thrombin-catalysed fibrin polymerization.
    Nakayama-Hamada M; Suzuki A; Furukawa H; Yamada R; Yamamoto K
    J Biochem; 2008 Sep; 144(3):393-8. PubMed ID: 18583356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of critical residues on thrombin mediating its interaction with fibrin.
    Hall SW; Gibbs CS; Leung LL
    Thromb Haemost; 2001 Dec; 86(6):1466-74. PubMed ID: 11776315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.